A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- Sysmex Challenger Sight Diagnostics Raises $71M As Capacity Soars 5-Foldon August 11, 2020 at 6:51 am
Sysmex revenues fell 12% while challenger Sight Diagnostics raised $71 million and quintupled manufacturing capacity. Is Sysmex losing market share?
- Covid-19 Diagnostics Market to Generate $445.4 Million by the Fourth Quarter of 2020on August 10, 2020 at 5:24 am
Significant increase in the incidence of coronavirus infection and lack of availability of specific medicine or vaccine drive the growth of the global ...
- Two Boulder diagnostics companies mergeon August 7, 2020 at 1:01 pm
Merging the companies will allow us to pursue a much larger market opportunity at a much faster pace than either of us could individually," said MBio CEO Chris Myatt in a prepared statement." ...
- Wearable fitness devices deliver early warning of possible COVID-19 infectionon August 7, 2020 at 7:59 am
But seeing a sudden change in these conditions can prompt people to isolate themselves and get diagnostic tests ... go before it can fit in wearable devices. Much of the ongoing research on developing ...
- Wearable fitness devices deliver early warning of possible COVID-19 infectionon August 7, 2020 at 5:35 am
Fitness information like resting heart rate collected by wearable devices can't diagnose diseases, but it can signal when something is wrong. That can be enough to prompt a COVID-19 test.
- Device Diagnoses Breast Cancer in 60 Minuteson August 6, 2020 at 8:29 am
Researchers have created a point-of-care device that can provide diagnostic information on the presence of breast cancer in under an hour. In initial validation studies, the device showed an accuracy ...
- Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistanceon August 5, 2020 at 7:29 am
A diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea and rapidly determining in under 30 minutes if the microorganism is susceptible to a single-dose ...
- Sight Diagnostics raises $71 million for blood-testing computer visionon August 5, 2020 at 7:00 am
Sight Diagnostics, a company developing a computer vision-based blood analyzer called Olo, has raised $71 million in venture capital.
- University of New Brunswick developing portable coronavirus diagnostic testson August 1, 2020 at 11:52 am
“Point-of-care devices, unlike other traditional tests ... Currently, there are two primary diagnostic methods available to detect the coronavirus. The first method reveals the presence of ...
- OraSure’s OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva Teston July 31, 2020 at 9:34 am
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its OMNIgene ...
via Bing News